Latest news
Insilico Nominates AI-Designed ISM9077, Potential First-in-Class Y Inhibitor, as Preclinical Candidate - Bioengineer.orgBioengineer.org · Thu, 06 Aug 2026 03:03:47 GMTHKEY-AI2Vivo™ 1.0: HKeyBio Accelerates In Vivo Translation for AI-Designed Candidates - Yahoo Finance SingaporeYahoo Finance Singapore · Thu, 30 Jul 2026 13:06:00 GMTFDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate - News-MedicalNews-Medical · Wed, 29 Jul 2026 07:00:00 GMT